TP53 and melanoma: Moreover, during melanoma development, several somatic alterations activate the MAPK and PI3K pathway, upregulate telomerase activity, modulate chromatin landscape, override the G1/S checkpoint, the ramp-up of MAPK signaling, and disrupt the p53 pathway14.